Original Research

Pathological response rate in hormone-positive breast cancer patients treated with neoadjuvant FEC and triweekly docetaxel: a case series

Kiba T, Morii N, Takahashi H, Ozaki S, Atsumi M, Masumoto F, Yamashiro H

Breast Cancer: Targets and Therapy 2015, 7:245-250

Published Date: 28 August 2015